0.4476
0.86%
-0.0039
Handel nachbörslich:
.45
0.0024
+0.54%
Schlusskurs vom Vortag:
$0.4515
Offen:
$0.4547
24-Stunden-Volumen:
629.92K
Relative Volume:
1.51
Marktkapitalisierung:
$19.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-49.11M
KGV:
-0.268
EPS:
-1.67
Netto-Cashflow:
$-33.81M
1W Leistung:
-4.77%
1M Leistung:
-0.91%
6M Leistung:
-41.03%
1J Leistung:
-81.50%
Spruce Biosciences Inc Stock (SPRB) Company Profile
Firmenname
Spruce Biosciences Inc
Sektor
Branche
Telefon
(415) 655-4168
Adresse
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO
Spruce Biosciences Inc Stock (SPRB) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2021-12-17 | Eingeleitet | Oppenheimer | Outperform |
2021-12-10 | Eingeleitet | The Benchmark Company | Speculative Buy |
2021-11-16 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2021-07-19 | Eingeleitet | H.C. Wainwright | Buy |
2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
2020-11-03 | Eingeleitet | Cowen | Outperform |
2020-11-03 | Eingeleitet | Credit Suisse | Outperform |
2020-11-03 | Eingeleitet | RBC Capital Mkts | Outperform |
2020-11-03 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Spruce Biosciences Inc Aktie (SPRB) Neueste Nachrichten
Checking in on Spruce Biosciences Inc (SPRB) after recent insiders movement - Knox Daily
Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance
Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Potential Price Increase for Spruce Biosciences Inc (SPRB) After Recent Insider Activity - Knox Daily
SPRBSpruce Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
An Inquiry Has Been Launched Into Whether Spruce Biosciences Inc. Violated Securities Regulations And Stockholders Are Encouraged To Assist - StockTitan
Spruce Biosciences Inc (SPRB) Becoming More Attractive for Investors - Knox Daily
SPRB (Spruce Biosciences) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com
SPRB (Spruce Biosciences) Dividends per Share : $0.00 (TTM As of Jun. 2024) - GuruFocus.com
Spruce Biosciences (NASDAQ:SPRB) Issues Quarterly Earnings Results, Beats Expectations By $0.10 EPS - Defense World
What technical indicators reveal about SPRB stock - US Post News
Spruce Biosciences’ (SPRB) Sector Perform Rating Reaffirmed at Royal Bank of Canada - Defense World
Spruce Biosciences Inc [SPRB] Insider Activity: An Update for Investors - Knox Daily
Ratios Reveal: Breaking Down Spruce Biosciences Inc (SPRB)’s Financial Health - The Dwinnex
SPRB stock touches 52-week low at $0.42 amid market challenges - Investing.com Australia
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace
Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - Manchestertimes
Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - Business Wire
SPRB stock touches 52-week low at $0.42 amid market challenges - Investing.com
Is Spruce Biosciences Inc (NASDAQ: SPRB) A Good Investment Now? - Stocks Register
Taking a look at what insiders are doing to gauge the Spruce Biosciences Inc (SPRB)’s direction - Knox Daily
Have you been able to find a good deal on Spruce Biosciences Inc’s shares? - US Post News
Market Recap: Spruce Biosciences Inc (SPRB)’s Negative Momentum, Closing at 0.45 - The Dwinnex
Nothing is Better Than Spruce Biosciences Inc (SPRB) stock at the moment - SETE News
Analysts review Spruce Biosciences Inc’s rating - Knox Daily
Ratio Revelations: Spruce Biosciences Inc (SPRB)’s Financial Metrics in the Spotlight - The Dwinnex
SPRB stock touches 52-week low at $0.5 amid market challenges - Investing.com
SPRB stock touches 52-week low at $0.5 amid market challenges - Investing.com Australia
Spruce Biosciences Inc [SPRB] Investment Appeal on the Rise - Knox Daily
Investors With Losses Are Urged To Initiate Dialogue As Spruce B - WICZ
Investors With Losses Are Urged To Initiate Dialogue As Spruce Biosciences Inc Is Being Investigated By The Schall Law Firm - AccessWire
The Schall Law Firm Is Carrying Out An Investigation Into Spruce - WICZ
368,831 Shares in Spruce Biosciences, Inc. (NASDAQ:SPRB) Acquired by Acadian Asset Management LLC - Defense World
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives Average Recommendation of “Hold” from Analysts - Defense World
Investors With Losses Encouraged To Initiate Dialogue As Spruce Biosciences Inc Is Being Investigated By The Schall Law Firm - AccessWire
Spruce Biosciences Inc (SPRB) stock: A year of ups and downs - US Post News
The Schall Law Firm Is Investigating Spruce Biosciences Incorpor - WICZ
Investors With Losses Are Urged To Start Conversation, Spruce Bi - WICZ
The Attractiveness of Investing In Spruce Biosciences Inc (SPRB) is Growing - Knox Daily
A closer look at Spruce Biosciences Inc (SPRB)’s stock price trends - US Post News
Daily Market Movement: Spruce Biosciences Inc (SPRB) Sees a 3.65 Increase, Closing at 0.57 - The Dwinnex
Spruce Biosciences, Inc. (NASDAQ:SPRB) Short Interest Update - Defense World
Was Spruce Biosciences Inc (SPRB)’s session last reading good? - US Post News
The Globe and Mail - The Globe and Mail
SPRB stock rated a Sector perform by RBC Capital Mkts - Knox Daily
The Schall Law Firm Begins Examination Into Spruce Biosciences I - WICZ
The Schall Law Firm Starts Scrutiny Of Spruce Biosciences Inc And Promotes Investors With Losses To Begin Communication - WICZ
Spruce Biosciences (NASDAQ:SPRB) and Adagene (NASDAQ:ADAG) Financial Contrast - Defense World
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Monitoring Spruce Biosciences Inc (SPRB) after recent insider movements – Knox Daily - Knox Daily
Finanzdaten der Spruce Biosciences Inc-Aktie (SPRB)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):